The SPARK Study: A phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury

Trials

Volumn 11, Issue , 2010, Pages

  Bagshaw, Sean M ^a   Gibney, RT Noel ^a   McAlister, Finlay A ^a   Bellomo, Rinaldo ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FUROSEMIDE; PLACEBO; DIURETIC AGENT;

ACID BASE BALANCE; ADULT; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE BALANCE; FEMALE; FLUID BALANCE; HUMAN; KIDNEY INJURY; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; URINE VOLUME; ACUTE DISEASE; BLOOD; CANADA; DISEASE COURSE; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; URINE;

ACUTE DISEASE; ADULT; ALBERTA; BIOLOGICAL MARKERS; CRITICAL ILLNESS; DISEASE PROGRESSION; DIURETICS; FEMALE; FUROSEMIDE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77953662362     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-50     Document Type: Article

References (47)

1. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007, 18:1292-1298. 10.1681/ASN.2006070756, 17314324.
2. Bagshaw SM, George C, Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007, 11:R68. 10.1186/cc5949, 2206434, 17588270.
3. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006, 17:1135-1142. 10.1681/ASN.2005060668, 16495381.
4. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
5. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005, 9:R700-R709. 10.1186/cc3879, 1414056, 16280066.
6. Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000, 26:1824-1831. 10.1007/s001340000726, 11271091.
7. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998, 66:S16-24.
8. Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D, Donaldson C. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 2003, 31:449-455. 10.1097/01.CCM.0000045182.90302.B3, 12576950.
9. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002, 30:2051-2058. 10.1097/00003246-200209000-00016, 12352040.
10. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. Jama 2009, 302:1179-1185. 10.1001/jama.2009.1322, 19755696.
11. Hamel MB, Phillips RS, Davis RB, Desbiens N, Connors AF, Teno JM, Wenger N, Lynn J, Wu AW, Fulkerson W, Tsevat J. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 1997, 127:195-202.
12. Kellum JA, Leblanc M, Gibney RTN, Tumlin J, Lieberthal W, Ronco C. Primary prevention of acute renal failure in the critically ill. Current Opinion in Critical Care 2005, 11(6):537-541.
13. Abel RM, Beck CH, Abbott WM, Ryan JA, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med 1973, 288:695-699.
14. De Torrente A, Miller PD, Cronin RE, Paulsin PE, Erickson AL, Schrier RW. Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol 1978, 235:F131-136.
15. Kramer HJ, Schuurmann J, Wassermann C, Dusing R. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int 1980, 17:455-464. 10.1038/ki.1980.53, 7392420.
16. Aravindan N, Aravindan S, Riedel BJ, Weng HR, Shaw AD. Furosemide prevents apoptosis and associated gene expression in a rat model of surgical ischemic acute renal failure. Ren Fail 2007, 29:399-407. 10.1080/08860220701263671, 17497460.
17. Aravindan N, Shaw A. Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. Ren Fail 2006, 28:25-35. 10.1080/08860220500461229, 16526316.
18. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009, 76:422-427. 10.1038/ki.2009.159, 19436332.
19. Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008, 12:R74. 10.1186/cc6916, 2481469, 18533029.
20. Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: A multinational survey. Contrib Nephrol 2007, 156:236-249. full_text, 17464133.
21. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Nacedo E, Gibney N, Tolwani A, Ronco C, Kellum JA, . Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators Diuretics and mortality in acute renal failure. Crit Care Med 2004, 32:1669-1677. 10.1097/01.CCM.0000132892.51063.2F, 15286542, Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators.
22. Cantarovich F, Fernandez JC, Locatelli A, Perez Loredo J. Frusemide in high doses in the treatment of acute renal failure. Postgraduate Medical Journal 1971, 47(Suppl):13-17.
23. Cantarovich F, Galli C, Benedetti L, Chena C, Castro L, Correa C, Perez Loredo J, Fernandez JC, Locatelli A, Tizado J. High dose frusemide in established acute renal failure. British Medical Journal 1973, 4:449-450. 10.1136/bmj.4.5890.449, 1587577, 4758446.
24. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004, 44:402-409. 10.1016/S0272-6386(04)00810-8, 15332212.
25. Chandra M, Agarwal SS, Mitra NK, Gupta NN. Massive intravenous frusemide therapy in acute renal failure. J Indian Med Assoc 1975, 64:47-48.
26. Lucas CE, Zito JG, Carter KM, Cortez A, Stebner FC. Questionable value of furosemide in preventing renal failure. Surgery 1977, 82:341-320.
27. Seedat YK. High dose frusemide in established acute renal failure. Br Med J 1973, 4:784. 10.1136/bmj.4.5895.784-b, 1587994, 4758583.
28. Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Annals of Thoracic Surgery 2000, 69:501-506. 10.1016/S0003-4975(99)01298-9, 10735688.
29. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992, 62:413-415. 10.1159/000187090, 1300436.
30. Zito J, Cortez A, Lucas CE, Stebner FC, Rosenberg IK, Jaanimagi JL. Distribution of renal blood flow after furosemide in critically ill patients. Surg Forum 1976, 27:27-29.
31. Mehta RL, Pascual MT, Soroko S, Chertow GM, Group PS. Diuretics, mortality, and nonrecovery of renal function in acute renal failure[see comment]. JAMA 2002, 288:2547-2553. 10.1001/jama.288.20.2547, 12444861.
32. Karayannopoulos S. High-dose frusemide in renal failure. Br Med J 1974, 2:278-279.
33. Kleinknecht D, Ganeval D, Gonzalez-Duque LA, J F. Furosemide in acute oliguric renal failure. A controlled trial. Nephron 1976, 17:51-58. 10.1159/000180710, 778649.
34. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrology Dialysis Transplantation 1997, 12:2592-2596.
35. Vargas Hein O, Staegemann M, Wagner D, von Heymann C, Martin M, Morgera S, Spies C. Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients. Renal Failure 2005, 27:385-392. 10.1081/JDI-65298, 16060124.
36. Kellum JA. Diuretics in acute renal failure: protective or deleterious. Blood Purif 1997, 15:319-322. 10.1159/000170350, 9435960.
37. Lameire N, Vanholder R, Van Biesen W. Loop diuretics for patients with acute renal failure: helpful or harmful?. Jama 2002, 288:2599-2601. 10.1001/jama.288.20.2599, 12444868.
38. Noble DW. Acute renal failure and diuretics: propensity, equipoise, and the need for a clinical trial. Critical Care Medicine 2004, 32:1794-1795. 10.1097/01.CCM.0000134836.50831.73, 15286565.
39. Schetz M. Should we use diuretics in acute renal failure?. Best Pract Res Clin Anaesthesiol 2004, 18:75-89. 10.1016/j.bpa.2003.09.003, 14760875.
40. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. Bmj 2006, 1553510, 16861256.
41. Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 2007, 9:68.
42. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-212. 10.1186/cc2872, 522841, 15312219.
43. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
44. Ostermann M, Alvarez G, Sharpe MD, Martin CM. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract 2007, 107:c70-76. 10.1159/000108641, 17890871.
45. Devine BJ. Gentamicin therapy. Drug Intell Clin Pharm 1974, 8:650-655.
46. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10:R73. 10.1186/cc4915, 1550961, 16696865.
47. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007, 2:431-439. 10.2215/CJN.03681106, 17699448, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.